Trial Profile
Effect of sitagliptin on insulin secretion and glucose metabolism in Japanese patients with type 2 diabetes mellitus
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 21 Nov 2012
Price :
$35
*
At a glance
- Drugs Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 05 Nov 2012 Status changed from recruiting to discontinued as reported by University Hospital Medical Information Network - Japan
- 27 Sep 2011 New trial record